## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-06-06T04:05:38.685Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Tidepool Mobile"
developer_entity: "Tidepool Project"
bundle_id: "org.tidepool.blipnotes"
app_store_id: "1026395200"
google_play_id: "io.tidepool.urchin"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2020-09-30"
report_date: "2026-06-06"
last_verified: "2026-06-06"
report_version: "3.1.3"
total_reviews: 152
overall_rating: 2.86
sentiment: "Mixed"
sentiment_score: 50
confidence: "medium"
confidence_score: 0.9
review_sample_size: 152
data_age_days: 0
momentum_velocity: "zombie"
intelligence_version: 3
nemesis: "mySugr - Diabetes Tracker Log"
competitor_count: 7
tags: ["medical", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "individuals", "managing", "diabetes"]
canonical_url: "https://marlvel.ai/intel-report/medical/tidepool-mobile"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Tidepool Mobile App Audit

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 2.86 · Sentiment Mixed

> **TL;DR:** Tidepool Mobile is a medical app by Tidepool Project, rated 2.86/5 by 152 users, with Mixed user sentiment (50/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Tidepool Mobile has Mixed user sentiment with a 2.86/5 rating from 152 reviews.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 2.86/5 (152 reviews) |
| **User Mood** | Mixed |
| **Category** | Medical |
| **Developer** | Tidepool Project |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.9/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Tidepool Project
- **Category:** Medical
- **Target Audience:** Individuals managing diabetes who use insulin pumps or CGMs, and their healthcare providers seeking centralized data for clinical decision-making.
- **Platforms:** iOS & Android
- **Version Audited:** 3.1.3
- **Audit Date:** 2026-06-06
- **Signal Count:** 152 reviews analyzed
- **Confidence:** Medium (0.9/1.0)
- **App Store ID (iOS):** 1026395200
- **Bundle ID:** org.tidepool.blipnotes
- **Google Play ID:** io.tidepool.urchin
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-06-06

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Tidepool Mobile is a companion uploader and notes app for diabetes device data, available on iOS and Android.
**Why users hire it:** Users hire Tidepool to centralize complex medical device data for clinical review, prioritizing data accuracy over the gamified engagement found in commercial trackers.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Data Uploader:** Automated data ingestion from Apple Health, insulin pumps, CGMs, and blood glucose meters.
- **[Standard] Contextual Notes:** Tagging and commenting system for CGM and pump data to provide qualitative context.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Big Data Donation:** Opt-in mechanism to share de-identified health data with the Tidepool Big Data Donation Project.
  * *User Intent:* Users seek social connection and competitive engagement with peers.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Tidepool Mobile maintains a niche presence in the medical category, with rankings such as #31 Free in Nepal. The platform's vendor-neutral stance differentiates it from hardware-locked competitors, though it lacks the high-frequency chart velocity of commercial trackers.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free access to all features and data platform
- **Analysis:** The platform operates as a non-profit, free-to-use service, focusing on data aggregation and clinical impact rather than direct consumer subscription revenue.

<!-- section:sentiment -->
## 🟡 User Sentiment (Medium Confidence: 152 reviews) {#user-sentiment}
- **Overall Rating:** 2.86/5
- **Platform Split:** iOS 2.8/5 (69 ratings) | Android 2.9/5 (83 ratings)
- **Overall Sentiment:** Mixed

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Vendor-neutral data interoperability across major pump and CGM brands
- Clinical-grade visualization supports telemedicine workflows
- Opt-in research donation creates high-value medical datasets

**Critical Frictions:**
- 2.8-star rating average across platforms
- Lack of real-time data streaming forces manual sync friction
- Interface design lacks consumer-friendly engagement loops

**Growth Levers:**
- Expand B2B partnerships with clinical research organizations
- Integrate wearable health data for holistic glucose-activity correlation

**Market Threats:**
- Commercial trackers with 2-week release cadences erode feature parity
- Hardware-bundled apps like Libre provide superior, zero-friction data ingestion

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The report transitioned from a basic feature overview to a critical competitive analysis, highlighting the product's reliance on manual syncs as a primary weakness against automated commercial trackers.

**Overall trend**: Mixed
**Compared at**: 2026-06-06

### High-impact changes
- **[Shifted] Critical Positioning Shift** (positioning) — Executive summary moved from neutral feature description to a critical assessment of manual sync friction and lack of engagement loops.
- **[Added] Sentiment Baseline Established** (sentiment) — Added user sentiment metrics including a 2.8-star rating and 152 reviews, identifying a 'mixed' overall sentiment.

### Medium-impact changes
- **[Improved] Data Uploader Repositioning** (features) — Competitive position for 'Data Uploader' upgraded from 'standard' to 'differentiator' due to its vendor-neutral interoperability.
- **[Shifted] Clinical Audience Inclusion** (audience) — Target audience expanded to include healthcare providers seeking centralized data for clinical decision-making.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Tidepool Mobile vs mySugr - Diabetes Tracker Log — Head to Head
- **[mySugr - Diabetes Tracker Log](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr)** by mySugr GmbH: Dominates the diabetes tracking niche with massive user scale and a high-frequency release cadence that keeps the product ahead of market expectations.
  - **Moat strength:** High — sustainable advantage over 12 months
  - **Key differences:**
    - Offers a gamified logging experience that significantly increases daily user engagement compared to standard manual trackers.
    - Provides automated data synchronization with a wider array of third-party glucose meters and insulin pumps.
    - Maintains a high-velocity release schedule, shipping nine updates in six months to address user feedback rapidly.
  - **Where Tidepool Mobile wins:**
    - ✅ Tidepool Mobile offers a more specialized, clinical-grade data visualization platform for complex insulin pump and CGM data.
    - ✅ The platform maintains a vendor-neutral stance, focusing on data interoperability rather than proprietary hardware ecosystem lock-in.
  - **Where mySugr - Diabetes Tracker Log wins:**
    - ❌ mySugr utilizes gamification mechanics like challenges and point-scoring to drive daily logging habits in casual users.
    - ❌ The app features a highly polished, consumer-friendly interface that simplifies complex medical data for non-clinical users.
  - **Verdict:** Tidepool must pivot from a 'companion uploader' to a 'patient-centric insights engine' to compete with mySugr's engagement-first design.

### Contenders (Strong Challengers)
- **[Libre by Abbott](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us)** by Abbott Labs [Moat: High]: Directly competes for the same CGM-focused user base with deep integration into the Abbott hardware ecosystem.
  - Provides native, real-time CGM data streaming that eliminates the need for manual data uploads or syncing.
  - Leverages proprietary hardware-software integration to create a seamless, high-fidelity user experience for Libre sensor wearers.
- **[OneTouch Reveal® app](https://marlvel.ai/intel-report/medical/com-lifescan-reveal)** by LifeScan, Inc. [Moat: Medium]: A major incumbent in the diabetes space that captures significant market share through hardware-bundled software.
  - Features automated pattern recognition that alerts users to recurring high or low blood glucose trends automatically.
  - Integrates directly with LifeScan blood glucose meters to provide a closed-loop data experience for patients.
- **[Glucose Buddy Diabetes Tracker](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy)** by Azumio Inc. [Moat: Medium]: A long-standing, highly-rated tracker that serves as a direct functional alternative for manual diabetes logging.
  - Includes comprehensive A1C tracking and medication logging features that go beyond simple glucose data visualization.
  - Offers a robust community-driven support system that provides social accountability for long-term diabetes management.

### Peers (What They Do Better)
- **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by MediSafe Inc.: Adjacent medical utility that focuses on medication adherence, a critical component of diabetes management.
  - Specializes in complex medication scheduling and refill reminders that are often missing from pure glucose trackers.
  - Utilizes a sophisticated notification engine to ensure users never miss a dose, improving overall health outcomes.
- **[athenaPatient](https://marlvel.ai/intel-report/medical/com-athenahealth-athenapatient)** by athenahealth: Represents the broader patient portal ecosystem that competes for the user's attention in clinical data management.
  - Provides direct access to clinical records, lab results, and provider messaging within a single, unified portal.
  - Leverages deep integration with healthcare provider workflows to ensure data accuracy and clinical relevance.

### New Kids on the Block (What's Innovative)
- **[Blood Pressure Tracker SmartBP](https://marlvel.ai/intel-report/medical/com-evolvemedicalsystems-sbp)** by Evolve Medical Systems, LLC: High-velocity updates and a focus on specific health metrics indicate an aggressive expansion into chronic condition tracking.

<!-- /section:rivals -->
<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Integrated Abbott FreeStyle Libre cloud sync.
- Added support for Eversense 365 CGM.

> **Cadence:** 5 total versions · 0 majors in last 6 months · 2031 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Tidepool Mobile is an established medical app that is completely free.
With a 2.86/5 rating from 152 reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** Tidepool Mobile provides a necessary clinical data bridge for diabetes management, but its manual-sync friction and lack of engagement loops leave it vulnerable to hardware-integrated trackers, so the product must pivot toward automated insights to retain users.
<!-- speakable-end -->

**Best for:** Individuals managing diabetes who use insulin pumps or CGMs, and their healthcare providers seeking centralized data for clinical decision-making.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Pivot the mobile interface to prioritize automated activity-glucose correlation because manual logging is the #1 churn driver → increase daily active habit. — *Manual logging is a known friction point in diabetes tracking apps, and the current 2.8-star rating suggests users are dissatisfied with the effort required.* _(trade-off: deprioritize Pause the research-donation feature expansion — engagement metrics are currently a higher priority for retention.)_
- [ ] [MAINTAIN] [HIGH IMPACT] Maintain the vendor-neutral data ingestion engine because it is the primary B2B moat against hardware-locked competitors → defend clinical partnership value. — *The platform's core value proposition is interoperability, which is the primary reason clinical partners choose Tidepool over proprietary hardware apps.* _(trade-off: deprioritize Same-quarter capacity available — no major lever displaced.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Real-time CGM data streaming (available in Libre by Abbott but absent here)
- Automated pattern recognition (available in OneTouch Reveal but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Mixed

The diabetes tracking market is consolidating around automated, hardware-integrated solutions that minimize user effort. Tidepool Mobile remains exposed due to its manual-sync reliance, so long-term viability depends on shifting from a data-uploader tool to an automated insights engine.

- 🔴 The lack of real-time data streaming forces manual syncs, which increases churn pressure as users migrate to hardware-native apps.
- 🟢 Recent cloud-to-cloud integrations with major CGM providers demonstrate active development, ensuring the platform remains relevant for clinical data aggregation.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 2.86/5 |
| Total Reviews | 152 |
| Sentiment | Mixed (50/100) |
| Confidence | Medium |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Tidepool Mobile** (this app) | 2.86/5 | Mixed | Tidepool Project |
| [Libre by Abbott](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us) | 4.6/5 | N/A | Abbott Labs |
| [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | Upset | MediSafe Inc. |
| [OneTouch Reveal® app](https://marlvel.ai/intel-report/medical/com-lifescan-reveal) | 4.8/5 | N/A | LifeScan, Inc. |
| [Blood Pressure Tracker SmartBP](https://marlvel.ai/intel-report/medical/com-evolvemedicalsystems-sbp) | 4.6/5 | N/A | Evolve Medical Systems, LLC |
| [Glucose Buddy Diabetes Tracker](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy) | 4.8/5 | Upset | Azumio Inc. |

## Company Profile
- **Developer:** Tidepool Project
- **Website:** [https://www.tidepool.org](https://www.tidepool.org)
- **Social:** [Instagram](https://www.instagram.com/zendesk) · [Facebook](https://www.facebook.com/zendesk) · [X/Twitter](https://www.twitter.com/zendesk) · [YouTube](https://www.youtube.com/zendesk) · [TikTok](https://www.tiktok.com/@zendesk) · [LinkedIn](https://www.linkedin.com/company/zendesk)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/tidepool-mobile/id1026395200?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=io.tidepool.urchin&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.tidepool.org)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*Libre by Abbott*](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us) (Abbott Labs) — 4.6/5 Rating | N/A Sentiment
- [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) — 4.7/5 Rating | Terrible Sentiment
- [*OneTouch Reveal® app*](https://marlvel.ai/intel-report/medical/com-lifescan-reveal) (LifeScan, Inc.) — 4.8/5 Rating | N/A Sentiment
- [*Blood Pressure Tracker SmartBP*](https://marlvel.ai/intel-report/medical/com-evolvemedicalsystems-sbp) (Evolve Medical Systems, LLC) — 4.6/5 Rating | N/A Sentiment
- [*Glucose Buddy Diabetes Tracker*](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy) (Azumio Inc.) — 4.8/5 Rating | Terrible Sentiment
- [*athenaPatient*](https://marlvel.ai/intel-report/medical/com-athenahealth-athenapatient) (athenahealth) — 4.9/5 Rating | N/A Sentiment
- [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr) (mySugr GmbH) — 4.7/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.9/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 152
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/tidepool-mobile)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.